Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Pharmaceuticals Major
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| PFE | Pfizer Inc. | 0.04% | 53.99 | 0.9% | $1408.53m | |
| JNJ | Johnson & Johnson | 0.02% | 179.57 | 0.7% | $1296.66m | |
| BMY | Bristol-Myers Squibb Co. | 0.52% | 77.99 | 1.0% | $1218.41m | |
| MRK | Merck & Co., Inc. | -0.31% | 92.03 | 0.7% | $1163.36m | |
| ABBV | AbbVie, Inc. | 0.34% | 151.07 | 1.9% | $1104.03m | |
| LLY | Eli Lilly & Co. | -0.15% | 313.00 | 1.1% | $965.80m | |
| BHVN | Biohaven Pharmaceutical Holding Co. Ltd. | -0.14% | 142.98 | 0.0% | $491.89m | |
| AZN | AstraZeneca Plc | -0.12% | 66.62 | 1.0% | $490.91m | |
| NVS | Novartis AG | -0.57% | 90.74 | 0.2% | $258.37m | |
| GSK | GlaxoSmithKline Plc | -0.42% | 44.23 | 0.2% | $256.49m | |
| VERU | Veru, Inc. | -0.16% | 12.62 | 0.0% | $253.31m | |
| HZNP | Horizon Therapeutics Plc | 0.00% | 90.59 | 5.4% | $196.03m | |
| SGEN | Seagen Inc. | 0.00% | 138.46 | 5.7% | $185.67m | |
| NVO | Novo Nordisk A/S | -1.18% | 105.36 | 0.1% | $180.73m | |
| VTRS | Viatris, Inc. | -0.42% | 11.96 | 0.0% | $164.58m |
Company Profile
Aerie Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of therapies for the treatment of patients with open-angle glaucoma, retinal diseases and other diseases of the eye. Its products include Rhopressa, Roclatan, AR-13503, and AR-1105. The company was founded by David L. Epstein, Casey C. Kopczynski, Thomas J. van Haarlem, and Eric J. Toone on January 1, 2005 and is headquartered in Durham, NC.